WS #15794
U.S. bankruptcy filings have risen 11% year-over-year, reaching nearly 470,000 in the first nine months of 2026, signaling deepening economic stress for consumers and small businesses. Concurrently, Walmart's move to cover GLP-1 drug costs for employees reflects a broader corporate strategy to manage rising healthcare expenditures. These factors, combined with global supply chain disruptions from Middle East tensions, suggest a macro environment where defensive stocks and healthcare providers may outperform cyclical growth assets.
Macroeconomic Stress Signals
U.S. bankruptcy filings have risen 11% year-over-year, reaching nearly 470,000 in the first nine months of 2026, signaling deepening economic stress for consumers and small businesses. Concurrently, Walmart's move to cover GLP-1 drug costs for employees reflects a broader corporate strategy to manage rising healthcare expenditures. These factors, combined with global supply chain disruptions from Middle East tensions, suggest a macro environment where defensive stocks and healthcare providers may outperform cyclical growth assets.